Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 14, 2017

View Archived Issues

Sutro and Celgene refocus their immune-oncology collaboration

Hanyang University discovers novel SAPK1a, SAPK1b and SAPK1c inhibitors

NEOMED Institute presents bromodomain and extraterminal domain protein inhibitors

New Bruton tyrosine kinase inhibitors patented by InnoCare Pharma

Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical patents bile acid receptor antagonists

Novel S1P5 agonists identified at Ono Pharmaceutical

BMTP-11 demonstrates efficacy in preclinical models of human osteosarcoma

Heterozygous Gnal knock-out mice as a novel model of DYT25-associated dystonia

First-in-human results for CART-EGFRvIII cell therapy in patients with recurrent glioblastoma

Rat HCV-related hepacivirus used to create model of HCV infection

Shire's Onivyde approved in Canada for metastatic adenocarcinoma of the pancreas

LipimetiX Development product given U.S. orphan status for homozygous familial hypercholesterolemia

Actelion's cadazolid named orphan drug in the U.S. for pediatric clostridium difficile infection

FDA grants DCC-2618 orphan status for glioblastoma multiforme and anaplastic astrocytomas

iPS Academia Japan and Tokyo Women's Medical University sign license agreement

NovoBiotic Pharmaceuticals is awarded SBIR phase I NIH NIAID grant

NIH awards three grants to researchers at Albert Einstein College of Medicine

Diamyd Medical and Cardiff University to collaborate on study of Diamyd diabetes vaccine

Inotersen and IONIS-FB-LRx to be independently developed by Ionis Pharmaceuticals

Akonni Biosystems is awarded NIH contract

First patient dosed in phase I extension trial of fimaCHEM

Klaria and Purdue Pharma to codevelop KL-00514

Protea enters collaboration research agreement with Massachusetts General Hospital

PreveCeutical Medical signs research collaboration letter of intent with UniQuest